FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine and can be used for treating and relieving pain. That is ensured by administering a pharmaceutical composition containing sulfamate derivatives or a pharmaceutically acceptable salt thereof. Also disclosed are sulphamate compounds and a pharmaceutical composition for preventing and treating pain.
EFFECT: group of inventions provides treating pain in a subject.
30 cl, 12 tbl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
PLATINUM (II) COMPLEX COMPOUNDS, METHOD OF THEIR SYNTHESIS, INTERMEDIATE COMPOUNDS AND METHODS OF THEIR SYNTHESIS | 1991 |
|
RU2067099C1 |
AMINOPYRAZOLOPYRIMIDINE COMPOUND USED AS INHIBITOR OF TYROSINE KINASE RECEPTOR OF NEUROTROPHIC FACTOR | 2017 |
|
RU2764523C2 |
DERIVATIVES OF CYCLOHEXANE OR TETRAHYDROPYRANE OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, OR HYDRATES, OR SOLVATES OF THESE COMPOUNDS, OR THEIR SALTS, INTERMEDIATE COMPOUNDS FOR THEIR SYNTHESIS AND FUNGICIDE AGENT | 1992 |
|
RU2084439C1 |
SPLICEOSTATIN ANALOGS | 2013 |
|
RU2618523C2 |
MELANOCORTIN RECEPTOR AGONISTS | 2007 |
|
RU2411240C2 |
CLASS OF BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUNDS FOR TARGETED DESTRUCTION OF ANDROGEN RECEPTORS AND USE THEREOF | 2020 |
|
RU2825000C2 |
CETP INHIBITORS | 2006 |
|
RU2513107C2 |
NOVEL PHENYL PYRROLE DERIVATIVE | 2009 |
|
RU2470917C2 |
COMPOUNDS AND COMPOSITIONS USED FOR TREATMENT OF NTRK-RELATED DISORDERS | 2016 |
|
RU2744974C2 |
BICYCLIC KETONES AND METHODS OF THEIR USE | 2018 |
|
RU2797922C2 |
Authors
Dates
2019-09-03—Published
2014-12-12—Filed